Welcome Guest
Home > Clinical Colorectal Cancer > Volume 6 | Supplement 2

Table of Contents

Volume 6 | Supplement 2

Publication Date: October 2007
  • Abstract
  • No Access
  • Pay-Per View
  • Full Text
  • Add to Cart


Contributions

S42-S46		 First-Line Use of Anti–Epidermal Growth Factor Receptor Monoclonal Antibodies in Metastatic Colorectal Cancer
James J. Lee, Edward Chu

S47-S52		 The Role of Epidermal Growth Factor Receptor–Targeted Antibody Therapy in Previously Treated Colorectal Cancer
David Watkins, David Cunningham

S53-S59		 Combining Targeted Therapies to Enhance the Effectiveness of Chemotherapy in Patients with Treatment-Refractory Colorectal Cancer
Cathy Eng

S60-S65		 Optimizing Administration of Epidermal Growth Factor Receptor–Targeted Agents in the Treatment of Colorectal Cancer
Eric Van Cutsem
  1. https://www.ceteresopolitano.org/
  2. https://www.crossingstoronto.com/
  3. https://www.jediism.org/
  4. https://www.badenumc.org/
  5. https://www.johnsevierchapter.org/
  6. https://www.trinitychapelmn.org/
  7. https://www.photogearnews.com/
  8. https://www.alz-nova.org/
  9. https://www.cigjournals.com/
  10. https://summa-edu.com/
  11. https://cpawilmingtonnc.org/
  12. https://bimometals.com/
  13. https://sosenvironmental.com/
  14. https://thefriary.org/
  15. https://post5theatre.org/
  1. KELUARAN SGP
  2. TOGEL